Qianshi Mixture Treats Diabetic Nephropathy by Regulating Lipid Metabolism Reprogramming and Inhibiting Oxidative Stress Damage
Journal of Cellular and Molecular Medicine · 2025
DOI: 10.1111/jcmm.70628 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Jian Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chinese Medicine, Cangzhou Hospital of Integrated Traditional Chinese Medicine and Western Medicine of Hebei, Cangzhou, China. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Oxidative Stress, Lipid Metabolism, Drugs, Chinese Herbal. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Hebei Provincial Administration of Traditional Chinese Medicine 2022 Traditional Chinese Medicine research, the Natural Science Foundation of Hebei Province, the Key Laboratory for Diabetic Kidney Disease Syndrome and Treatment of the Traditional Chinese Medicine Administration.
Abstract (Originalsprache)
Diabetic nephropathy (DN) is a major complication of diabetes that can advance to end‐stage renal disease, posing a substantial health risk. The Qianshi Mixture (QSM) has shown therapeutic potential for DN; however, its pharmacological mechanisms remain insufficiently understood. We developed a DN model in mice and administered QSM as an intervention. To assess QSM's therapeutic effects, we measured the renal‐function‐related biochemical indicators and examined kidney pathological changes. We then applied transcriptomics and non‐targeted metabolomics to explore QSM's impact on gene expression and metabolic products within DN mice renal tissues. Based on our multi‐omics analysis, the effect of QSM on lipid‐metabolism‐related protein expression was confirmed by western blot in kidney tissue. Additionally, we evaluated the antioxidant and anti‐apoptotic properties of QSM by measuring oxidative stress indicators. QSM intervention improved hyperglycemia and proteinuria in DN mice. It also reduced key markers of renal dysfunction whilst alleviating pathological changes in kidney tissue. Through transcriptomic and metabolomic analyses, we identified that QSM affected genes and metabolites involved in lipid metabolism pathways. Notably, differentially expressed genes included Ces2h , Ces1f and Alox5 , whilst metabolites such as EPA, 9‐Oxo‐ODE and LPC (20:3) were altered. Further validation revealed that QSM increased the protein levels of CES2H and CES1F whilst decreasing the expression of FABP1, CD36, ALOX15 and ALOX5. Additionally, QSM reduced oxidative stress markers. QSM inhibited both oxidative stress and apoptosis in kidney tissues. QSM protects renal tissues in DN, likely through the regulation of lipid metabolism and the mitigation of oxidative stress damage.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chinese Medicine, Cangzhou Hospital of Integrated Traditional Chinese Medicine and Western Medicine of Hebei, Cangzhou, China.
- Department of Graduate School, Hebei University of Traditional Chinese Medicine, Shijiazhuang, China.
- Department of Graduate School, Guangxi University of Chinese Medicine, Nanning, China.
- Department of Graduate School, Shanxi University of Chinese Medicine, Taiyuan, China.
- Department of Chinese Medicine, Cangzhou Central Hospital, Cangzhou, China.
- Department of Endocrinology, Cangzhou Hospital of Integrated Traditional Chinese Medicine and Western Medicine of Hebei, Cangzhou, China.
ORCID-Profile: Huantian Cui
Förderung
- the Hebei Provincial Administration of Traditional Chinese Medicine 2022 Traditional Chinese Medicine research
- the Natural Science Foundation of Hebei Province
- the Key Laboratory for Diabetic Kidney Disease Syndrome and Treatment of the Traditional Chinese Medicine Administration
- Hebei Province famous traditional Chinese medicine inheritance studio construction project
- Natural Science Foundation of Hebei Province
Zitieren
APA
Liu, J., Liu, B., Fan, E., Zhang, H., Yin, Z., Lv, S., Wen, W., Min, F., Zhang, Z., & Cui, H. (2025). Qianshi Mixture Treats Diabetic Nephropathy by Regulating Lipid Metabolism Reprogramming and Inhibiting Oxidative Stress Damage. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70628
Vancouver
Liu J, Liu B, Fan E, Zhang H, Yin Z, Lv S, et al. Qianshi Mixture Treats Diabetic Nephropathy by Regulating Lipid Metabolism Reprogramming and Inhibiting Oxidative Stress Damage. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70628
BibTeX
@article{Liu2025,
author = {Liu, Jian and Liu, Boning and Fan, Enzhi and Zhang, Han and Yin, Zhonglai and Lv, Shuquan and Wen, Weibo and Min, Feitian and Zhang, Zhongyong and Cui, Huantian},
title = {Qianshi Mixture Treats Diabetic Nephropathy by Regulating Lipid Metabolism Reprogramming and Inhibiting Oxidative Stress Damage},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
doi = {10.1111/jcmm.70628}
}
EUVIMED